Helmholtz Gemeinschaft

Search
Browse
Statistics
Feeds

Browse by Research Team

Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item Type | Source
Jump to: 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1998 | 1997 | 1996

2018

Deletion of protein kinase D1 in pancreatic β-cells impairs insulin secretion in high-fat diet-fed mice.
Bergeron, V. and Ghislain, J. and Vivot, K. and Tamarina, N. and Philipson, L.H. and Fielitz, J. and Poitout, V.
Diabetes 67 (1): 71-77. January 2018

2017

Excitotoxic inactivation of constitutive oxidative stress detoxification pathway in neurons can be rescued by PKD1.
Pose-Utrilla, J. and García-Guerra, L. and Del Puerto, A. and Martin, A. and Jurado-Arjona, J. and De León-Reyes, N.S. and Gamir-Morralla, A. and Sebastián-Serrano, A. and García-Gallo, M. and Kremer, L. and Fielitz, J. and Ireson, C. and Pérez-Álvarez, M.J. and Ferrer, I. and Hernández, F. and Ávila, J. and Lasa, M. and Campanero, M.R. and Iglesias, T.
Nature Communications 8 (1): 2275. 22 December 2017

Secreted frizzled-related protein 2 and inflammation-induced skeletal muscle atrophy.
Zhu, X. and Kny, M. and Schmidt, F. and Hahn, A. and Wollersheim, T. and Kleber, C. and Weber-Carstens, S. and Fielitz, J.
Critical Care Medicine 45 (2): e169-e183. February 2017

Deletion of Nlrp3 protects from inflammation-induced skeletal muscle atrophy.
Huang, N. and Kny, M. and Riediger, F. and Busch, K. and Schmidt, S. and Luft, F.C. and Slevogt, H. and Fielitz, J.
Intensive Care Medicine Experimental 5 (1): 3. 17 January 2017

Insulin regulates astrocytic glucose handling through cooperation with IGF-I.
Fernandez, A.M. and Hernandez-Garzón, E. and Perez-Domper, P. and Perez-Alvarez, A. and Mederos, S. and Matsui, T. and Santi, A. and Trueba-Saiz, A. and Garcia-Guerra, L. and Pose-Utrilla, J. and Fielitz, J. and Olson, E.N. and Fernandez de la Rosa, R. and Garcia Garcia, L. and Pozo, M.A. and Iglesias, T. and Araque, A. and Soya, H. and Perea, G. and Martin, E.D. and Torres Aleman, I.
Diabetes 66 (1): 64-74. January 2017

2016

Cancer cachexia-when proteasomal inhibition is not enough.
Fielitz, J.
Journal of Cachexia Sarcopenia and Muscle 7 (3): 239-245. June 2016

Critical illness polyneuropathy in ICU patients is related to reduced motor nerve excitability caused by reduced sodium permeability.
Koch, S. and Bierbrauer, J. and Haas, K. and Wolter, S. and Grosskreutz, J. and Luft, F.C. and Spies, C.D. and Fielitz, J. and Weber-Carstens, S.
Intensive Care Medicine Experimental 4 (1): 10. 20 May 2016

Muscle RING-finger 2 and 3 maintain striated-muscle structure and function.
Lodka, D. and Pahuja, A. and Geers-Knörr, C. and Scheibe, R. and Nowak, M. and Hamati, J. and Köhncke, C. and Purfürst, B. and Kanashova, T. and Schmidt, S. and Glass, D.J. and Morano, I. and Heuser, A. and Kraft, T. and Bassel-Duby, R. and Olson, E.N. and Dittmar, G. and Sommer, T. and Fielitz, J.
Journal of Cachexia Sarcopenia and Muscle 7 (2): 165-180. May 2016

2015

Angiotensin II induces skeletal muscle atrophy by activating TFEB-mediated MuRF1 expression.
Du Bois, P. and Pablo Tortola, C. and Lodka, D. and Kny, M. and Schmidt, F. and Song, K. and Schmidt, S. and Bassel-Duby, R. and Olson, E.N. and Fielitz, J.
Circulation Research 117 (5): 424-436. 14 August 2015

Induction of Ankrd1 in dilated cardiomyopathy correlates with the heart failure progression.
Bogomolovas, J. and Brohm, K. and Čelutkiené, J. and Balčiūnaité, G. and Bironaité, D. and Bukelskiené, V. and Daunoravičus, D. and Witt, C.C. and Fielitz, J. and Grabauskiené, V. and Labeit, S.
BioMed Research International 2015 : 273936. 2015

2014

The E3 ubiquitin ligase TRIM62 and inflammation-induced skeletal muscle atrophy.
Schmidt, F. and Kny, M. and Zhu, X. and Wollersheim, T. and Persicke, K. and Langhans, C. and Lodka, D. and Kleber, C. and Weber-Carstens, S. and Fielitz, J.
Critical Care 18 (5): 545. 29 September 2014

Inflammation-induced acute phase response in skeletal muscle and critical illness myopathy.
Langhans, C. and Weber-Carstens, S. and Schmidt, F. and Hamati, J. and Kny, M. and Zhu, X. and Wollersheim, T. and Koch, S. and Krebs, M. and Schulz, H. and Lodka, D. and Saar, K. and Labeit, S. and Spies, C. and Hubner, N. and Spranger, J. and Spuler, S. and Boschmann, M. and Dittmar, G. and Butler-Browne, G. and Mouly, V. and Fielitz, J.
PLoS ONE 9 (3): e92048. 20 March 2014

Dynamics of myosin degradation in intensive care unit-acquired weakness during severe critical illness.
Wollersheim, T. and Woehlecke, J. and Krebs, M. and Hamati, J. and Lodka, D. and Luther-Schroeder, A. and Langhans, C. and Haas, K. and Radtke, T. and Kleber, C. and Spies, C. and Labeit, S. and Schuelke, M. and Spuler, S. and Spranger, J. and Weber-Carstens, S. and Fielitz, J.
Intensive Care Medicine 40 (4): 528-538. 15 February 2014

2013

Critical illness myopathy and GLUT4 - significance of insulin and muscle contraction.
Weber-Carstens, S. and Schneider, J. and Wollersheim, T. and Assmann, A. and Bierbrauer, J. and Marg, A. and Al Hasani, H. and Chadt, A. and Wenzel, K. and Koch, S. and Fielitz, J. and Kleber, C. and Faust, K. and Mai, K. and Spies, C.D. and Luft, F.C. and Boschmann, M. and Spranger, J. and Spuler, S.
American Journal of Respiratory and Critical Care Medicine 187 (4): 387-396. 15 February 2013

2012

G protein-coupled receptor (GPR)40-dependent potentiation of insulin secretion in mouse islets is mediated by protein kinase D1.
Ferdaoussi, M. and Bergeron, V. and Zarrouki, B. and Kolic, J. and Cantley, J. and Fielitz, J. and Olson, E.N. and Prentki, M. and Biden, T. and Macdonald, P.E. and Poitout, V.
Diabetologia 55 (10): 2682-2692. October 2012

Early type II fiber atrophy in intensive care unit patients with nonexcitable muscle membrane.
Bierbrauer, J. and Koch, S. and Olbricht, C. and Hamati, J. and Lodka, D. and Schneider, J. and Luther-Schroeder, A. and Kleber, C. and Faust, K. and Wiesener, S. and Spies, C.D. and Spranger, J. and Spuler, S. and Fielitz, J. and Weber-Carstens, S.
Critical Care Medicine 40 (2): 647-650. February 2012

2011

Skeletal muscle 11beta-HSD1 controls glucocorticoid-induced proteolysis and expression of E3 ubiquitin ligases atrogin-1 and MuRF-1.
Biedasek, K. and Andres, J. and Mai, K. and Adams, S. and Spuler, S. and Fielitz, J. and Spranger, J.
PLoS ONE 6 (1): e16674. 31 January 2011

2010

Myocyte enhancer factor 2 and class II histone deacetylases control a gender-specific pathway of cardioprotection mediated by the estrogen receptor.
van Rooij, E. and Fielitz, J. and Sutherland, L.B. and Thijssen, V.L. and Crijns, H.J. and Dimaio, M.J. and Shelton, J. and De Windt, L.J. and Hill, J.A. and Olson, E.N.
Circulation Research 106 (1): 155-165. 8 January 2010

2008

Protein kinase D1 stimulates MEF2 activity in skeletal muscle and enhances muscle performance.
Kim, M.S. and Fielitz, J. and McAnally, J. and Shelton, J.M. and Lemon, D.D. and McKinsey, T.A. and Richardson, J.A. and Bassel-Duby, R. and Olson, E.N.
Molecular and Cellular Biology 28 (11): 3600-3609. June 2008

Requirement of protein kinase D1 for pathological cardiac remodeling.
Fielitz, J. and Kim, M.S. and Shelton, J.M. and Qi, X. and Hill, J.A. and Richardson, J.A. and Bassel-Duby, R. and Olson, E.N.
Proceedings of the National Academy of Sciences of the United States of America 105 (8): 3059-3063. 26 February 2008

Up-regulation of PPARgamma in myocardial infarction.
Fliegner, D. and Westermann, D. and Riad, A. and Schubert, C. and Becher, E. and Fielitz, J. and Tschope, C. and Regitz-Zagrosek, V.
European Journal of Heart Failure 10 (1): 30-38. January 2008

2007

Myosin accumulation and striated muscle myopathy result from the loss of muscle RING finger 1 and 3.
Fielitz, J. and Kim, M.S. and Shelton, J.M. and Latif, S. and Spencer, J.A. and Glass, D.J. and Richardson, J.A. and Bassel-Duby, R. and Olson, E.N.
Journal of Clinical Investigation 117 (9): 2486-2495. September 2007

Histone deacetylases 1 and 2 redundantly regulate cardiac morphogenesis, growth, and contractility.
Montgomery, R.L. and Davis, C.A. and Potthoff, M.J. and Haberland, M. and Fielitz, J. and Qi, X. and Hill, J.A. and Richardson, J.A. and Olson, E.N.
Genes & Development 21 (14): 1790-1802. 15 July 2007

Inhibition of prolyl 4-hydroxylase prevents left ventricular remodelling in rats with thoracic aortic banding.
Fielitz, J. and Philipp, S. and Herda, L.R. and Schuch, E. and Pilz, B. and Schubert, C. and Gunzler, V. and Willenbrock, R. and Regitz-Zagrosek, V.
European Journal of Heart Failure 9 (4): 336-342. April 2007

Loss of muscle-specific RING-finger 3 predisposes the heart to cardiac rupture after myocardial infarction.
Fielitz, J. and van Rooij, E. and Spencer, J.A. and Shelton, J.M. and Latif, S. and van der Nagel, R. and Bezprozvannaya, S. and de Windt, L. and Richardson, J.A. and Bassel-Duby, R. and Olson, E.N.
Proceedings of the National Academy of Sciences of the United States of America 104 (11): 4377-4382. 13 March 2007

2006

Stabilization of hypoxia inducible factor rather than modulation of collagen metabolism improves cardiac function after acute myocardial infarction in rats.
Philipp, S. and Juergensen, J.S. and Fielitz, J. and Bernhardt, W.M. and Weidemann, A. and Schiche, A. and Pilz, B. and Dietz, R. and Regitz-Zagrosek, V. and Eckardt, K.U. and Willenbrock, R.
European Journal of Heart Failure 8 : 347-354. June 2006

2005

Mechanisms of blood pressure variability-induced cardiac hypertrophy and dysfunction in mice with impaired baroreflex.
Martinka, P. and Fielitz, J. and Patzak, A. and Regitz-Zagrosek, V. and Persson, P.B. and Stauss, H.M.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 288 (3): R767-R776. March 2005

2004

Regulation of matrix metalloproteinases and their inhibitors in the left ventricular myocardium of patients with aortic stenosis.
Fielitz, J. and Leuschner, M. and Zurbruegg, H.R. and Hannack, B. and Pregla, R. and Hetzer, R. and Regitz-Zagrosek, V.
Journal of Molecular Medicine 82 (12): 809-820. December 2004

Upregulation of myocardial estrogen receptors in human aortic stenosis.
Nordmeyer, J. and Eder, S. and Mahmoodzadeh, S. and Martus, P. and Fielitz, J. and Bass, J. and Bethke, N. and Zurbruegg, H.R. and Pregla, R. and Hetzer, R. and Regitz-Zagrosek, V.
Circulation 110 (20): 3270-3275. 16 November 2004

A small molecular activator of cardiac hypertrophy uncovered in a chemical screen for modifiers of the calcineurin signaling pathway.
Bush, E. and Fielitz, J. and Melvin, L. and Martinez-Arnold, M. and McKinsey, T.A. and Plichta, R. and Olson, E.N.
Proceedings of the National Academy of Sciences of the United States of America 101 (9): 2870-2875. 2 March 2004

2003

Effects of therapeutic beta blockade on myocardial function and cardiac remodelling in congenital cardiac disease.
Buchhorn, R. and Hulpke-Wette, M. and Ruschewski, W. and Ross, R.D. and Fielitz, J. and Pregla, R. and Hetzer, R. and Regitz-Zagrosek, V.
Cardiology In The Young 13 (1): 36-43. February 2003

2002

beta-receptor downregulation in congenital heart disease: a risk factor for complications after surgical repair?
Buchhorn, R. and Hulpke-Wette, M. and Ruschewski, W. and Pregla, R. and Fielitz, J. and Hetzer, R. and Regitz-Zagrosek, V.
Annals of Thoracic Surgery 73 : 610-613. 1 February 2002

Neutral endopeptidase is activated in cardiomyocytes in human aortic valve stenosis and heart failure.
Fielitz, J. and Dendorfer, A. and Pregla, R. and Ehler, E. and Zurbruegg, H.R. and Bartunek, J. and Hetzer, R. and Regitz-Zagrosek, V.
Circulation 105 : 286-289. 22 January 2002

2001

Activation of the cardiac renin-angiotensin system and increased myocardial collagen expression in human aortic valve disease.
Fielitz, J. and Hein, S. and Mitrovic, V. and Pregla, R. and Zurbruegg, H.R. and Warnecke, C. and Schaper, J. and Fleck, E. and Regitz-Zagrosek, V.
Journal of the American College of Cardiology 37 (5): 1443-1449. April 2001

2000

Angiotensin II directly increases transforming growth factor beta1 and osteopontin and indirectly affects collagen mRNA expression in the human heart.
Kupfahl, C. and Pink, D. and Friedrich, K. and Zurbruegg, H.R. and Neuss, M. and Warnecke, C. and Fielitz, J. and Graf, K. and Fleck, E. and Regitz-Zagrosek, V.
Cardiovascular Research 46 (3): 463-475. June 2000

1998

Myocardial angiotensin receptors in human hearts.
Regitz-Zagrosek, V. and Fielitz, J. and Fleck, E.
Basic Research in Cardiology 93 Suppl 2 : 37-42. 1998

1997

Angiotensin receptor type 1 mRNA in human right ventricular endomyocardial biopsies: downregulation in heart failure.
Regitz-Zagrosek, V. and Fielitz, J. and Dreysse, R. and Hildebrandt, A.G. and Fleck, E.
Cardiovascular Research 35 (1): 99-105. July 1997

1996

Decreased expression of ventricular angiotensin receptor type 1 mRNA after human heart transplantation.
Regitz-Zagrosek, V. and Fielitz, J. and Hummel, M. and Hildebrandt, A.G. and Hetzer, R. and Fleck, E.
Journal of Molecular Medicine 74 (12): 777-782. December 1996

This list was generated on Sun Dec 16 02:21:44 2018 CET.
Open Access
MDC Library